The Endocannabinoid System as a Therapeutic Target in Glaucoma

Glaucoma is an irreversible blinding eye disease which produces progressive retinal ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk factor, and lowering IOP results in reduced risk of progression of the disorder. The endocannabinoid system (ECS) has attract...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neural plasticity. - 1998. - 2016(2016) vom: 15., Seite 9364091
1. Verfasser:	Cairns, Elizabeth A (VerfasserIn)
Weitere Verfasser:	Baldridge, William H, Kelly, Melanie E M
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2016
Zugriff auf das übergeordnete Werk:	Neural plasticity
Schlagworte:	Journal Article Research Support, Non-U.S. Gov't Review Cannabinoid Receptor Agonists Cannabinoids Endocannabinoids Neuroprotective Agents Receptors, Cannabinoid